11:01:19 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



Alliance Growers Corp
Symbol ACG
Shares Issued 59,870,309
Close 2018-03-14 C$ 0.41
Market Cap C$ 24,546,827
Recent Sedar Documents

ORIGINAL: Alliance Growers expands cannabis-centre plan

2018-03-15 10:56 ET - News Release

Received by email:

File: ACG_NR Botany Centre Advancement 031518 final.docx

0/

ALLIANCE GROWERS CORP.

NEWS RELEASE

ALLIANCE GROWERS ANNOUNCES PROJECT UPDATES

March 15, 2018 - Vancouver, B.C. - Alliance Growers Corp. (CSE: ACG; FWB: 1LA; WKN: A2DFYX) ("Alliance Growers" or the
---> "Company") is pleased to report several key advancements for the Cannabis Botany Centre. In a news release dated Dece
--->mber 30, 2017, Alliance Growers announced that it has entered into a binding Letter of Intent ("LOI") with WFS Pharmag
--->reen Inc. ("Pharmagreen"), and the execution of this LOI initiated the development of the Cannabis Botany Centre that 
--->Alliance and Pharmagreen have been working on for the past year. 
Alliance Growers and Pharmagreen are pleased to report the following key notable advancements:
Design upgrades of the facility have been completed to include the increased handling of 10 Million plantlets per year
---> from previous annual capacity of 3 Million
Included in the design upgrades are state-of-the-art semi automation processes to ensure consistent and high-quality p
--->roduction of plantlets for an ever-growing demand as the number and size of cannabis production facilities keeps expan
--->ding 
The Cannabis Botany Center and its services offered are high value-added products and services for both the domestic a
--->nd international cannabis industry.
Annual gross revenue from the tissue culture operations are expected to be $50 Million per year with 10 million plantl
--->ets produced and sold at $5 per plantlet. 
Commenting on the advancements and progress at the Cannabis Botany Centre, Alliance Growers President and CEO, Dennis 
--->Petke stated, "The 30 percent ownership in the Botany Centre is the first of many sustainable and high margin revenue 
--->streams for the company in the next 12 to 14 months. We all know, the medical cannabis space is here to stay, and Alli
--->ance will be one of the few medical cannabis companies that will continue to grow in value and revenue year-after-year
---> due to its diversified global business model. I am especially pleased with the relationships that Alliance has built 
--->over the last year thanks to various members of the team.  We have financing commitments in place to ensure we can exe
--->cute on each phase of each project when required.  In a volatile market, those commitments are critical".
Alliance Growers is also pleased to report that due diligence on the strategic investment in a private licensed Jamaic
--->an cannabis company is near completion. This investment is another step in the Alliance model to be a global medial ca
--->nnabis company being developed for where the market is going, not where it is now. The investment in the Jamaican comp
--->any was previously reported in a news release on February 27, 2018. 
About Alliance Growers
Alliance Growers is a diversified cannabis company driven by the Company's 'Four Pillars' Organization Plan - Cannabis
---> Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.
Alliance Growers has finalized its a new business partnership with WFS Pharmagreen Inc., to jointly develop and operat
--->e a 40,000-square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction fa
--->cility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in genera
--->l. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, spec
--->ifically the "Chibafreen Invitro Plant Production System", which assures consistent composition and purity of each pla
--->ntlet for the growers.
Alliance Growers has entered into an exclusive agreement to acquire a late stage licensed producer applicant, Biocanna
--->tech, to become a licensed producer under Health Canada's access to cannabis for medical purposes regulations ("ACMPR"
--->) in Quebec.  Alliance Growers will supply financing and resources to build out the medical marijuana facility in prep
--->aration for the inspection required to obtain a growing license. Once Health Canada is satisfied with a successful cro
--->p, Alliance Growers will be granted its distribution license.  This acquisition allows the Company an opportunity to b
--->ecome a licensed producer in the Province of Quebec and gain an in-road to provide tissue culture plantlets to all lic
--->ensed producers in Quebec.
Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain 
--->proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed P
--->roducer Applicants at various stages in the Health Canada License process.
For further information, please visit the Company's website at www.alliancegrowers.com or the Company's profile at www
--->.sedar.com. 
If you would like to be added to Alliance Growers' news distribution list, please send your email address to newslette
--->r@alliancegrowers.com
On behalf of the board of directors of
ALLIANCE GROWERS CORP.
"Dennis Petke"
Dennis Petke
President and CEO
For more information contact:
Dennis Petke
Tel: 778-331-4266
DennisPetke@alliancegrowers.com  

Rob Grace
Communications Consultant
Tel: 778-998-5431
RobDGrace@gmail.com

THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF T
--->HIS RELEASE.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable
---> securities laws. These statements relate to future events or future performance. All statements other than statements
---> of historical fact may be forward-looking statements or information. More particularly and without limitation, the ne
--->ws release contains forward-looking statements and information relating to Company's corporate strategy. The forward-l
--->ooking statements and information are based on certain key expectations and assumptions made by management of the Comp
--->any, including, without limitation, the Company's ability to carry out its business plan. Although management of the C
--->ompany believes that the expectations and assumptions on which such forward-looking statements and information are bas
--->ed are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assu
--->rance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current exp
--->ectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such s
--->tatements and information may not be appropriate for other purposes, such as making investment decisions. Since forwar
--->d-looking statements and information address future events and conditions, by their very nature they involve risks and
---> uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and
---> risks. These include, but are not limited to, the Company's ability to identify and complete additional suitable acqu
--->isitions to further the Company's growth as well as risks associated with the medical marijuana industry in general, s
--->uch as operational risks in development and production delays or changes in plans with respect to development projects
---> or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, 
--->production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets;
---> environmental risks; competition; incorrect assessment of the value of the potential market; ability to access suffic
--->ient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes
---> in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not plac
--->e undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers 
--->are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no un
--->dertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of 
--->new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securiti
--->es Exchange. The forward-looking statements or information contained in this news release are expressly qualified by t
--->his cautionary statement.






© 2024 Canjex Publishing Ltd. All rights reserved.